| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0034504 | BP | protein localization to nucleus | A process in which a protein is transported to, or maintained in, a location within the nucleus. |
TOR1A, XPO1, PLRG1, DNAJB6, CTDNEP1, COL1A1, LMNA, BMP4, CALR, SOX9, RPL11, MDM2, HHEX, ZBTB16, CNEP1R1, BANP, SYNE2, PIKFYVE |
GO:0034505 | BP | tooth mineralization | The process in which calcium salts are deposited into calcareous tooth structures such as dental enamel, dentin and cementum. |
COL1A1 |
GO:0034508 | BP | centromere complex assembly | The aggregation, arrangement and bonding together of proteins and centromeric DNA molecules to form a centromeric protein-DNA complex. Includes the formation of the chromatin structures which form a platform for the kinetochore, and assembly of the kinetochore onto this specialized chromatin. In fission yeast and higher eukaryotes this process also includes the formation of heterochromatin at the outer repeat (pericentric) regions of the centromere. |
CENPV |
GO:0034511 | MF | U3 snoRNA binding | Interacting selectively and non-covalently with U3 small nucleolar RNA. |
SNU13, TSR1, ISG20 |
GO:0034512 | MF | box C/D snoRNA binding | Interacting selectively and non-covalently with box C/D small nucleolar RNA. |
SNU13 |
GO:0034513 | MF | box H/ACA snoRNA binding | Interacting selectively and non-covalently with box H/ACA small nucleolar RNA. |
DKC1, NOP10, GAR1 |
GO:0034515 | CC | proteasome storage granule | A multisubunit proteasome complex that localizes in the cytoplasm as dot-like structures when cells are in a quiescent state. |
PSMD2 |
GO:0034516 | BP | response to vitamin B6 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B6 stimulus. Vitamin B6 encompasses pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate. |
KYNU |
GO:0034518 | CC | RNA cap binding complex | Any protein complex that binds to a specialized RNA cap structure at any time in the lifetime of the RNA. |
NCBP1, NCBP3 |
GO:0034551 | BP | mitochondrial respiratory chain complex III assembly | The aggregation, arrangement and bonding together of a set of components to form the cytochrome bc(1) complex (also known as ubiquinol-cytochrome c reductase), in the mitochondrial inner membrane. |
UQCRB, TTC19, UQCC3, UQCC2, UQCR10, BCS1L |
GO:0034584 | MF | piRNA binding | Interacting selectively and non-covalently with a piRNA, a Piwi-associated RNA, a 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism. |
PIWIL4 |
GO:0034587 | BP | piRNA metabolic process | The chemical reactions and pathways involving piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism. |
PIWIL4, TDRD9 |
GO:0034589 | BP | hydroxyproline transport | The directed movement of hydroxyproline into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
SLC1A4 |
GO:0034590 | MF | L-hydroxyproline transmembrane transporter activity | Enables the transfer of L-hydroxyproline from one side of a membrane to the other. |
SLC1A4 |
GO:0034594 | MF | phosphatidylinositol trisphosphate phosphatase activity | Catalysis of the reaction: phosphatidylinositol trisphosphate + H2O = phosphatidylinositol bisphosphate + phosphate. |
INPP5K |
GO:0034595 | MF | phosphatidylinositol phosphate 5-phosphatase activity | Catalysis of the removal of the 5-phosphate group of a phosphatidylinositol phosphate. |
SYNJ1, INPP5K |
GO:0034596 | MF | phosphatidylinositol phosphate 4-phosphatase activity | Catalysis of the removal of the 4-phosphate group of a phosphatidylinositol phosphate. |
SYNJ2, SYNJ1 |
GO:0034597 | MF | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity | Catalysis of the reaction: 1-phosphatidyl-myo-inositol 4,5-bisphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 3-phosphate + phosphate. |
INPP4B, INPP4A |
GO:0034599 | BP | cellular response to oxidative stress | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
FOXO3, PRKRA, STAU1, PENK, GPX1, PARP1, HSPA1A, HSPA1B, G6PD, ATP2A2, NME2, MT3, PRDX2, SNCA, ETV5, NR4A2, SESN2, FOXO1, HDAC1, NFE2L1, PRKD1, ADNP2, SETX, CPEB2, SIRT2, PNPT1, TXN2, VIMP, PINK1, FANCD2, ATP13A2, SEPN1, PPARGC1A |
GO:0034602 | MF | oxoglutarate dehydrogenase (NAD+) activity | Catalysis of the reaction: 2-oxoglutarate + CoA + NAD+ = succinyl-CoA + CO2 + NADH. |
OGDH |
GO:0034604 | MF | pyruvate dehydrogenase (NAD+) activity | Catalysis of the reaction: pyruvate + CoA + NAD+ = acetyl-CoA + CO2 + NADH. |
PDHA1, DLD, DLAT, PDHB |
GO:0034605 | BP | cellular response to heat | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
TFEC, PDCD6, IL1A, EIF2S1, LYN, THBS1, HMOX1, HSPA1A, HSPA1B, TPR, HSPA6, CDKN1A, MKI67, IRAK1, ATXN3, HSF1, C11orf73, TRPV1, HDAC2, STAC, TRPV4, SLC52A3, ARPP21 |
GO:0034612 | BP | response to tumor necrosis factor | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
ADAM10, MAP2K7, UBD, JAK2, CD14, SELE, PTGS2, CHI3L1, AFF3, IGBP1, ADAM9, RIPK1, CASP8, ADIPOQ, MAP4K3, CXCL16, YTHDC2, NUB1, TNFRSF11A |
GO:0034613 | BP | cellular protein localization | Any process in which a protein is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell. |
RAP2A, DMD, CTNNA1, WNT5A, ID4, CSNK1E, NLRP5, CDC42, ANK2, KCNA1, AMOT, LAMTOR1, NIPBL, AHI1, AJUBA, FRMD6, RRAGC, RRAGD, LATS2, ARMCX3, LAMTOR3, PRPF19, LAMTOR2 |
GO:0034614 | BP | cellular response to reactive oxygen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
FOS, TPM1, PDGFRA, MPV17, AKR1C3, ROMO1, PKD2, PTPRK, PPARGC1B |
GO:0034616 | BP | response to laminar fluid shear stress | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls. |
SMAD7, SMAD6, ABCA1, TGFB1, ETS1, ADAM9 |
GO:0034617 | MF | tetrahydrobiopterin binding | Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions. |
TH, NOS3 |
GO:0034618 | MF | arginine binding | Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid. |
NOS3, RARS |
GO:0034620 | BP | cellular response to unfolded protein | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus. |
PARK2, RHBDD1, PACRG |
GO:0034625 | BP | fatty acid elongation, monounsaturated fatty acid | Elongation of a fatty acid chain into which one C-C double bond has been introduced. |
ELOVL7, ELOVL1, ELOVL4, ELOVL6, ELOVL5 |
GO:0034626 | BP | fatty acid elongation, polyunsaturated fatty acid | Elongation of a fatty acid chain into which two or more C-C double bonds have been introduced. |
ELOVL7, ELOVL1, ELOVL4, ELOVL6, ELOVL5 |
GO:0034628 | BP | de novo' NAD biosynthetic process from aspartate | The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of aspartate from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH. |
NMNAT3 |
GO:0034629 | BP | cellular protein complex localization | A protein complex localization process that takes place at the cellular level; as a result, a protein complex is transported to, or maintained in, a specific location within a cell. |
WASL, SMAD7, SNAPIN, EZR, DLG1, SEH1L |
GO:0034632 | MF | retinol transporter activity | Enables the directed movement of retinol into, out of or within a cell, or between cells. Retinol is vitamin A1, 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A. |
RBP4 |
GO:0034633 | BP | retinol transport | The directed movement of retinol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Retinol is vitamin A1, 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A. |
RBP4 |
GO:0034638 | BP | phosphatidylcholine catabolic process | The chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. |
ENPP2, PNPLA8 |
GO:0034644 | BP | cellular response to UV | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
TRIAP1, KDM1A, N4BP1, MYC, TP53, EIF2S1, PCNA, ATF4, YY1, PIK3R1, POLD1, CDC25A, PTGS2, CASP9, FMR1, BAX, EP300, NFATC4, PTPRK, RHBDD1, CREBBP, ERCC4, TP53INP1, AURKB, PBK, USP28, RHNO1, EIF2AK4, RUVBL2, NOC2L |
GO:0034645 | BP | cellular macromolecule biosynthetic process | The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, carried out by individual cells. |
PTH |
GO:0034647 | MF | histone demethylase activity (H3-trimethyl-K4 specific) | Catalysis of the removal of a methyl group from trimethylated lysine at position 4 of the histone H3 protein. |
KDM5B |
GO:0034648 | MF | histone demethylase activity (H3-dimethyl-K4 specific) | Catalysis of the removal of a methyl group from dimethylated lysine at position 4 of the histone H3 protein. |
KDM1A, KDM5B |
GO:0034650 | BP | cortisol metabolic process | The chemical reactions and pathways involving cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties. |
CYP11A1 |
GO:0034651 | BP | cortisol biosynthetic process | The chemical reactions and pathways resulting in the formation of cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties. |
CYP11B1, CYP11B2 |
GO:0034653 | BP | retinoic acid catabolic process | The chemical reactions and pathways resulting in the breakdown of retinoic acid, one of the three components that makes up vitamin A. |
CYP26A1, CYP26B1 |
GO:0034656 | BP | nucleobase-containing small molecule catabolic process | The chemical reactions and pathways resulting in the breakdown of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide. |
NUDT1, NUDT16, NUDT9, NUDT15, NUDT5 |
GO:0034657 | CC | GID complex | A protein complex with ubiquitin ligase activity that is involved in proteasomal degradation of fructose-1,6-bisphosphatase (FBPase) and phosphoenolpyruvate carboxykinase during the transition from gluconeogenic to glycolytic growth conditions. In S. cerevisiae, the GID (Glucose Induced degradation Deficient) complex consists of Vid30p, Rmd5p, Vid24p, Vid28p, Gid7p, Gid8p, and Fyv10p. |
MAEA, RMND5B, RMND5A |
GO:0034663 | CC | endoplasmic reticulum chaperone complex | A protein complex that is located in the endoplasmic reticulum and is composed of chaperone proteins, including BiP, GRP94; CaBP1, protein disulfide isomerase (PDI), ERdj3, cyclophilin B, ERp72, GRP170, UDP-glucosyltransferase, and SDF2-L1. |
P4HB, HSPA5, HSP90B1, PPIB, PDIA6, DNAJC10, HYOU1 |
GO:0034665 | CC | integrin alpha1-beta1 complex | An integrin complex that comprises one alpha1 subunit and one beta1 subunit. |
ITGB1 |
GO:0034666 | CC | integrin alpha2-beta1 complex | An integrin complex that comprises one alpha2 subunit and one beta1 subunit. |
ITGB1, LYN, ITGA2 |
GO:0034667 | CC | integrin alpha3-beta1 complex | An integrin complex that comprises one alpha3 subunit and one beta1 subunit. |
ITGB1, ITGA3 |
GO:0034670 | BP | chemotaxis to arachidonic acid | The directed movement of a motile cell or organism in response to the presence of arachidonic acid. |
CREB1 |
GO:0034673 | CC | inhibin-betaglycan-ActRII complex | A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B. |
INHA, ACVR2A, TGFBR3 |
GO:0034676 | CC | integrin alpha6-beta4 complex | An integrin complex that comprises one alpha6 subunit and one beta1 subunit. |
ITGA6 |
GO:0034677 | CC | integrin alpha7-beta1 complex | An integrin complex that comprises one alpha7 subunit and one beta1 subunit. |
ITGB1 |
GO:0034678 | CC | integrin alpha8-beta1 complex | An integrin complex that comprises one alpha8 subunit and one beta1 subunit. |
ITGB1 |
GO:0034679 | CC | integrin alpha9-beta1 complex | An integrin complex that comprises one alpha9 subunit and one beta1 subunit. |
ITGA9 |
GO:0034680 | CC | integrin alpha10-beta1 complex | An integrin complex that comprises one alpha10 subunit and one beta1 subunit. |
ITGA10, ITGB1 |
GO:0034681 | CC | integrin alpha11-beta1 complex | An integrin complex that comprises one alpha11 subunit and one beta1 subunit. |
ITGB1, ITGA11 |
GO:0034683 | CC | integrin alphav-beta3 complex | An integrin complex that comprises one alphav subunit and one beta3 subunit. |
ITGB3, ITGAV |
GO:0034684 | CC | integrin alphav-beta5 complex | An integrin complex that comprises one alphav subunit and one beta5 subunit. |
ITGAV, ITGB5 |
GO:0034686 | CC | integrin alphav-beta8 complex | An integrin complex that comprises one alphav subunit and one beta8 subunit. |
ITGAV, ITGB8 |
GO:0034687 | CC | integrin alphaL-beta2 complex | An integrin complex that comprises one alphaL subunit and one beta2 subunit. |
ITGB2 |
GO:0034695 | BP | response to prostaglandin E | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus. |
GNRH1, TGFBR3 |
GO:0034696 | BP | response to prostaglandin F | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin F stimulus. |
EDN1, YY1 |
GO:0034698 | BP | response to gonadotropin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus. |
ICAM1, ITGA3 |
GO:0034699 | BP | response to luteinizing hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus. |
TGFBR3 |
GO:0034702 | CC | ion channel complex | A protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
LRRC8A |
GO:0034704 | CC | calcium channel complex | An ion channel complex through which calcium ions pass. |
PRKACA, CALM2, PDE4D, AKAP6, CAMK2D, PPP2R4, RYR3, MICU2, RYR2 |
GO:0034705 | CC | potassium channel complex | An ion channel complex through which potassium ions pass. |
KCNK1 |
GO:0034706 | CC | sodium channel complex | An ion channel complex through which sodium ions pass. |
SCNN1A, SCNN1G |
GO:0034707 | CC | chloride channel complex | An ion channel complex through which chloride ions pass. |
FXYD1, CLIC1, BEST1, CLIC3, CFTR, GABRA5, CLCNKA, CLCNKB, ANO6, BEST3, CLIC6, TTYH1, ANO2, CLIC5 |
GO:0034709 | CC | methylosome | A large (20 S) protein complex that possesses protein arginine methyltransferase activity and modifies specific arginines to dimethylarginines in the arginine- and glycine-rich domains of several spliceosomal Sm proteins, thereby targeting these proteins to the survival of motor neurons (SMN) complex for assembly into small nuclear ribonucleoprotein (snRNP) core particles. Proteins found in the methylosome include the methyltransferase JBP1 (PRMT5), pICln (CLNS1A), MEP50 (WDR77), and unmethylated forms of SM proteins that have RG domains. |
SNRPB, SNRPF, SNRPD1, SNRPD2, SNRPD3, ERH, PRMT1 |
GO:0034711 | MF | inhibin binding | Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers. |
INHA, INHBA, ACVR2A, ACVR1B |
GO:0034713 | MF | type I transforming growth factor beta receptor binding | Interacting selectively and non-covalently with a type I transforming growth factor beta receptor. |
SMAD7, SMAD6, TGFB1, TGFBR2, SMAD2 |
GO:0034714 | MF | type III transforming growth factor beta receptor binding | Interacting selectively and non-covalently with a type III transforming growth factor beta receptor. |
TGFB1, TGFB2 |
GO:0034715 | CC | pICln-Sm protein complex | A protein complex that contains pICln (CLNS1A) and several Sm proteins, including SmD1, SmD2, SmE, SmF, and SmG. |
SNRPF, SNRPD1, SNRPD2, SNRPD3 |
GO:0034719 | CC | SMN-Sm protein complex | A protein complex formed by the association of several methylated Sm proteins with the SMN complex; the latter contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and unrip proteins; additional proteins, including galectin-1 and galectin-3, are also found in the SMN-SM complex. The SMN-Sm complex is involved in spliceosomal snRNP assembly in the cytoplasm. |
SNRPB, GEMIN4, SNRPF, SNRPD1, SNRPD2, SNRPD3, GEMIN5, GEMIN6, GEMIN8, DDX20 |
GO:0034720 | BP | histone H3-K4 demethylation | The modification of histone H3 by the removal of a methyl group from lysine at position 4 of the histone. |
KDM1A, KDM5A, KDM5B |
GO:0034721 | BP | histone H3-K4 demethylation, trimethyl-H3-K4-specific | The modification of histone H3 by the removal of a methyl group from a trimetylated lysine at position 4 of the histone. |
KDM5B |
GO:0034722 | MF | gamma-glutamyl-peptidase activity | Catalysis of the cleavage of a gamma-linked glutamate bond. |
GGH |
GO:0034736 | MF | cholesterol O-acyltransferase activity | Catalysis of the reaction: acyl-CoA + cholesterol = a cholesterol ester + CoA. |
SOAT1 |
GO:0034750 | CC | Scrib-APC-beta-catenin complex | A protein complex that contains the Scribble protein (a cell polarity determinant), the tumor suppressor protein adenomatous polyposis coli (APC), and beta-catenin; may be involved in the control of cell proliferation. |
CTNNB1 |
GO:0034751 | CC | aryl hydrocarbon receptor complex | A protein complex that acts as an aryl hydrocarbon (Ah) receptor. Cytosolic and nuclear Ah receptor complexes have different subunit composition, but both contain the ligand-binding subunit AhR. |
AIP |
GO:0034752 | CC | cytosolic aryl hydrocarbon receptor complex | An aryl hydrocarbon receptor complex found in the cytosol, in which the ligand-binding subunit AhR is not bound to ligand; consists of AhR, two molecules of HSP90, the protein kinase c-Src, and the immunophilin XAP2/AIP. |
AHR |
GO:0034753 | CC | nuclear aryl hydrocarbon receptor complex | An aryl hydrocarbon receptor (AhR) complex found in the nucleus; ; consists of ligand-bound AhR and the aryl hydrocarbon receptor nuclear translocator (ARNT). |
AHR |
GO:0034755 | BP | iron ion transmembrane transport | A process in which an iron ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
TTYH1, SLC40A1 |
GO:0034763 | BP | negative regulation of transmembrane transport | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other. |
CTTNBP2NL |
GO:0034765 | BP | regulation of ion transmembrane transport | Any process that modulates the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other. |
GPR89A, CLIC1, WWP2, CACNA1G, CLIC3, CYBB, GPR89B, KCNA1, KCNMA1, KCNC3, KCNJ12, SCN9A, CACNA1E, ASIC2, TPCN2, KCNG3, KCNV2, KCNE4, TMEM37, CLIC6, NEDD4L, KCNK17, CACNG6, KCNK12, CLIC5, KCNK6 |
GO:0034767 | BP | positive regulation of ion transmembrane transport | Any process that activates or increases the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other. |
ANO6 |
GO:0034769 | BP | basement membrane disassembly | The controlled breakdown of the basement membrane in the context of a normal process such as imaginal disc eversion. |
CTSS |
GO:0034770 | BP | histone H4-K20 methylation | The modification of histone H4 by addition of one or more methyl groups to lysine at position 20 of the histone. |
WHSC1, KMT5A |
GO:0034773 | BP | histone H4-K20 trimethylation | The modification of histone H4 by addition of three methyl groups to lysine at position 20 of the histone. |
PWP1, KMT5B, ARID4B, KMT5C |
GO:0034774 | CC | secretory granule lumen | The volume enclosed by the membrane of a secretory granule. |
POMC, GCG, INS, APOA1, TF, PCSK1, GHRL |
GO:0034776 | BP | response to histamine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter. |
DRD2 |
GO:0034875 | MF | caffeine oxidase activity | Catalysis of the reaction: caffeine + O2 + 2 H+ + 2 e- = 1,3,7-trimethyluric acid + H2O. |
CYP3A4, CYP2C9 |
GO:0034959 | BP | endothelin maturation | The process leading to the attainment of the full functional capacity of endothelin by conversion of Big-endothelin substrate into mature endothelin. |
ECE1 |
GO:0034968 | BP | histone lysine methylation | The modification of a histone by addition of one or more methyl groups to a lysine residue. |
PRDM2, SETD6, SETD7, EHMT2, WHSC1L1, SMYD3, PRDM6 |
GO:0034969 | BP | histone arginine methylation | The modification of a histone by addition of a methyl group to an arginine residue. |
PRMT3 |
GO:0034970 | BP | histone H3-R2 methylation | The modification of histone H3 by addition of a methyl group to arginine at position 2 of the histone. |
CARM1, PRMT6 |
GO:0034971 | BP | histone H3-R17 methylation | The modification of histone H3 by addition of a methyl group to arginine at position 17 of the histone. |
CARM1, NR1H4 |
GO:0034975 | BP | protein folding in endoplasmic reticulum | A protein folding process that takes place in the endoplasmic reticulum (ER). Secreted, plasma membrane and organelle proteins are folded in the ER, assisted by chaperones and foldases (protein disulphide isomerases), and additional factors required for optimal folding (ATP, Ca2+ and an oxidizing environment to allow disulfide bond formation). |
HSPA5, HSP90B1, CALR, CANX, PDIA3, ERO1B, DNAJC10, EMC1, ERO1A, EMC3 |